Dr sHosseini SBMU Summer 2019 INTRODUCTION Breast cancer is the most common type of cancer among young adult women Quality of life for cancer survivors is important because of the high survival rate due to early diagnosis and improvements in cancer treatment ID: 1037632
Download Presentation The PPT/PDF document "Fertility Preservation in Breast Cancer" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1. Fertility Preservation in Breast CancerDr s.HosseiniSBMUSummer 2019
2. INTRODUCTIONBreast cancer is the most common type of cancer among young adult womenQuality of life for cancer survivors is important because of the high survival rate due to early diagnosis and improvements in cancer treatment
3. why preservation?Gonadotoxic chemotherapyLong –lasting adjuvant therapiesNon-pharmacologic ovarian suppressionRadiation therapy ?
4. introductionASCO guidelines recommend : health care providers should inform cancer patients about the possibility of infertility Should also be prepared to discuss FP options and /or to refer all potential patients to appropriate reproductive specialists
5. introductionmore than 90% of young breast cancer patients showed to be concerned about the potential risk of developing chemotherapy-induced premature ovarian insufficiency and/or infertility only 12% of them decided to access cryopreservation strategies
6. effect of chemotherapyPatient ageFamilial ovarian historyOvarian follicle reserveHistory of previous ovarian and pelvic surgeryPrevious chemotherapyPrevious pelvic and abdominal radiotherapyPersistent high level of FSHClass of the chemotherapeutic agent(alkylating vs nonalkylating)Concomitant other diseasesDosing and length of chemotherapy
7.
8.
9. endocrine therapyWhile young women are more likely to have TN or HER2 amplified breast cancer, a large proportion of women have estrogen receptor positive (ER+) breast cancerEndocrine therapy has resulted in a significant increase in disease-free and overall survival for women with ER+ breast cancer
10. endocrine therapy5 year or 10 year In ER positive cancerPostpone pregnancy
11. Fertility Preservation StrategiesOocyte CryopreservationEmbryo CryopreservationOvarian tissue CryopreservationGnRh suppression
12. ovarian stimulation oocyte and embryo cryopreservation need ovarian stimulation, which results in increased serum estradiol levels that may accelerate breast cancer growth. In order to avoid estradiol elevation, the protocol of ovarian stimulation with aromatase inhibitor (AI) was proposed as the protocol is unlikely to increase recurrence
13. A recent systematic review of letrozole for ovarian hyperstimulation demonstrated: adequate oocyte yield low estradiol levels no effect on breast cancer recurrence rates.
14.
15.
16. Time?Random start ovarian stimulation
17.
18. Oocyte cryopreservationMature oocytesImmature oocytes( in vitro maturation)
19. Ovarian cryopreservationThe cumulative clinical and LB + OG rates were 57.5% and 37.7%, respectively, and the endocrine restoration rate was 63.9%.Success rates with cryopreserved OTT have reached promising levels. Given these recent data, ovarian tissue cryopreservation should be considered as a viable option for FP.
20.
21. The efficacy of GnRH therapy for fertility preservation is difficult to assess because many studies have used unreliable or non-suitable surrogate outcomes. most of the studies have assessed the treatment in women with different types of diseases
22. Fertility preservation with ART was not associated with treatment delay in patients with breast cancer who were referred to reproductive specialists before cancer treatment
23.